Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02581930
Title Ibrutinib in Treating Patients With Refractory Stage IV Cutaneous Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

skin melanoma

Therapies

Ibrutinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.